Signup Crypto ETF Stocks News

Cruise demand is 'exceptionally high,' says Royal Caribbean Group CEO

Royal Caribbean Group CEO Jason Liberty states that cruise demand is "exceptionally high," indicating a robust outlook for the sector. CNBC's Contessa Brewer interviewed Liberty to discuss the current state and future prospects of the cruise industry. The interview provides insights into the strong recovery and ongoing growth of the travel sector.

Source: CNBC
April 14, 2026 | 12:44:18
Category: General

Why Intuitive Surgical Stock Has an $850 Mid-Case Target in Play

Intuitive Surgical (ISRG) delivered a strong 2025, with revenue up 21% and EPS up 21.7%, driven by growth across its da Vinci, Ion, and Single Port platforms, and a significant new FDA clearance for cardiac procedures with da Vinci 5. Despite this performance and a TIKR model target of $849.20, the stock is currently trading below its recent valuation multiples. The article analyzes the low, mid, and high case scenarios for future growth, highlighting potential challenges like tariffs and the stapler recall, as well as opportunities from cardiac adoption and international expansion.

Source: TIKR.com
April 14, 2026 | 12:44:51
Category: General

What to Expect From Corteva's Q1 2026 Earnings Report

Corteva, Inc. (CTVA), a leading agricultural company, is set to release its Q1 2026 earnings report, with analysts expecting a marginal increase in EPS to $1.14 per share. The company has consistently beaten EPS estimates in recent quarters and its stock has significantly outperformed both the S&P 500 and the State Street Materials Select Sector SPDR ETF over the past year. Analysts hold a "Moderate Buy" rating for CTVA, with an average price target indicating a slight upside.

Source: Barchart.com
April 14, 2026 | 12:45:22
Category: General

Here's What to Expect From Booking Holdings' Next Earnings Report

Booking Holdings Inc. (BKNG) is expected to announce its fiscal first-quarter earnings for 2026 after the market closes on Tuesday, April 28. Analysts anticipate an EPS of $1.11 per share, a 12.1% increase year-over-year. Despite consistent outperformance in EPS estimates, BKNG's stock has underperformed the S&P 500 over the past 52 weeks, attributed to geopolitical tensions and economic uncertainties.

Source: Barchart.com
April 14, 2026 | 12:49:13
Category: General

Erin Lichy shares her breast augmentation story in Natrelle campaign

Allergan Aesthetics, an AbbVie company, has partnered with entrepreneur Erin Lichy to share her personal breast augmentation journey with Natrelle® implants through social media. Lichy aims to promote transparency and normalize conversations around aesthetic procedures, encouraging patient education. The campaign highlights Natrelle®'s 50-year legacy, 10-year clinical safety profile, and offers a testimonial program for other women to share their experiences.

Source: Stock Titan
April 14, 2026 | 12:49:58
Category: General

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

Entrepreneur and TV personality Erin Lichy has partnered with Allergan Aesthetics to share her breast augmentation journey using Natrelle® breast implants. As a mother of four, Lichy hopes her transparency about the procedure will normalize conversations around aesthetic surgery and empower other women considering similar options. The article also provides important safety information and approved uses for Natrelle® breast implants.

Source: AbbVie News Center
April 14, 2026 | 12:51:58
Category: General

A long-term agreement brings Snapdragon XR solutions to future generations of Specs

Qualcomm Technologies and Specs Inc., a Snap subsidiary, have announced a multi-year strategic agreement to power future generations of Specs with Snapdragon system-on-a-chip (SoC) solutions. This collaboration aims to integrate digital experiences seamlessly into the physical world through Specs, advanced eyewear launching later this year. The partnership builds on a decade-long relationship between the companies, focusing on on-device AI, cutting-edge graphics, and advanced multiuser digital experiences to support developers and consumers.

Source: Techaeris
April 14, 2026 | 12:52:20
Category: General

Linde plc stock (IE00BZ12WP82): Is industrial gases demand strong enough to drive steady gains?

Linde plc, the world's largest industrial gases company, is well-positioned for resilient growth due to increasing demand for industrial gases in clean energy and manufacturing across global industries. The company's core business, stable long-term contracts, and investments in hydrogen projects make it an appealing prospect for investors. While analysts view Linde favorably, potential risks include energy costs, geopolitical tensions, and uncertainties in hydrogen commercialization.

Source: AD HOC NEWS
April 14, 2026 | 12:55:59
Category: General

ENPH Shareholder Alert: Enphase Energy, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm

The Gross Law Firm has issued a shareholder alert for investors of Enphase Energy, Inc. (NASDAQ: ENPH), announcing a securities class action lawsuit. Shareholders who purchased ENPH stock between April 22, 2025, and October 28, 2025, are encouraged to contact the firm regarding potential lead plaintiff appointment. The lawsuit alleges Enphase made false and misleading statements concerning its ability to manage channel inventory, mitigate effects of the 25D Credit termination, and overstated its financial prospects.

Source: PR Newswire
April 14, 2026 | 12:59:33
Category: General

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules – Company Announcement - FT.com

Waters Corporation has launched the omniDAWN Multi-Angle Light Scattering (MALS) Photometer, an industry-first extended-range MALS detector for UHPLC/UPLC workflows. This new photometer delivers up to four times faster chromatographic run times, a tenfold extension in UPLC-compatible sizing, and a 10x improvement in absolute molar mass and extended sizing. It aims to accelerate the characterization of large and complex molecules, improving efficiency in drug discovery, development, and quality control.

Source: Financial Times
April 14, 2026 | 12:59:34
Category: General

© Natavest 2025 - 2026